Status:
COMPLETED
Predictor for an Additional Benefit of Inhaled Corticosteroid in Patients Treated With Tiotropium for COPD
Lead Sponsor:
Cantonal Hosptal, Baselland
Conditions:
COPD
Eligibility:
All Genders
40+ years
Phase:
PHASE4
Brief Summary
Study purpose is to evaluate if subjects with chronic obstructive pulmonary disease (COPD) are more likely to be responsive to additional inhaled corticosteroids if they have a positive response to hy...
Detailed Description
In patients with chronic obstructive pulmonary disease (COPD), the treatment with inhaled corticosteroids (ICS) is controversial. Preliminary results of our recent pilot study in 30 COPD patients show...
Eligibility Criteria
Inclusion
- FEV1/FVC \< 70%
- FEV1 % predicted \> 60%
Exclusion
- Other major disease
- Asthma
- Currently taking inhaled corticosteroids
- oral corticosteroids in the last 3 month
- significant cardiovascular disease
- pregnancy/breast feeding
- current use of salmeterol or other long acting bronchodilator
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00860938
Start Date
April 1 2007
End Date
October 1 2010
Last Update
July 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Switzerland, 4031